Publication Cover
Biofouling
The Journal of Bioadhesion and Biofilm Research
Volume 37, 2021 - Issue 5
354
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Biofilm inhibition and antifouling evaluation of sol-gel coated silicone implants with prolonged release of eugenol against Pseudomonas aeruginosa

, & ORCID Icon
Pages 521-537 | Received 03 May 2020, Accepted 17 May 2021, Published online: 17 Jun 2021

References

  • Ahmed SAKS, Rudden M, Smyth TJ, Dooley JS, Marchant R, Banat IM. 2019. Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors. Appl Microbiol Biotechnol. 103:3521–3535. doi:10.1007/s00253-019-09618-0
  • Al-Qahtani M, Safan A, Jassim G, Abadla S. 2019. Efficacy of anti-microbial catheters in preventing catheter associated urinary tract infections in hospitalized patients: a review on recent updates. J Infect Public Health. 12:760–766. doi:10.1016/j.jiph.2019.09.009
  • Andersen MJ, Flores-Mireles AL. 2019. Urinary catheter coating modifications: the race against catheter-associated infections. Coatings. 10:23. doi:10.3390/coatings10010023
  • Azevedo AS, Almeida C, Melo LF, Azevedo NF. 2017. Impact of polymicrobial biofilms in catheter-associated urinary tract infections. Crit Rev Microbiol. 43:423–439. doi:10.1080/1040841X.2016.1240656
  • Böttcher H, Jagota C, Trepte J, Kallies KH, Haufe H. 1999. Sol-gel composite films with controlled release of biocides. J Control Release. 60:57–65. doi:10.1016/s0168-3659(99)00053-x
  • Brinker CJ, Scherer GW. 2013. Sol-gel science: the physics and chemistry of sol-gel processing. San Diego (CA): Academic Press.
  • Brooks T, Keevil CW. 1997. A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol. 24:203–206. doi:10.1046/j.1472-765x.1997.00378.x
  • Caresani JR, Lattuada RM, Radtke C, dos Santos JH. 2014. Attempts made to heterogenize MAO via encapsulation within silica through a non-hydrolytic sol–gel process. Powder Technol. 252:56–64. doi:10.1016/j.powtec.2013.10.015
  • Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. 2008. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol. 6:17–27. doi:10.1038/nrmicro1818
  • Chong HY, Lai NM, Apisarnthanarak A, Chaiyakunapruk N. 2017. Comparative efficacy of antimicrobial central venous catheters in reducing catheter-related bloodstream infections in adults: abridged Cochrane systematic review and network meta-analysis. Clin Infect Dis. 64:S131–S140. doi:10.1093/cid/cix019
  • Defoirdt T. 2018. Quorum-sensing systems as targets for antivirulence therapy. Trends Microbiol. 26:313–328. doi:10.1016/j.tim.2017.10.005
  • Dehghanghadikolaei A, Ansary J, Ghoreishi R. 2018. Sol-gel process applications: a mini-review. Proc Nat Res Soc. 2:02008. doi:10.11605/j.pnrs.201802008
  • Dickey SW, Cheung GY, Otto M. 2017. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 16:457–471. doi:10.1038/nrd.2017.23
  • Fasugba O, Koerner J, Mitchell BG, Gardner A. 2017. Systematic review and meta-analysis of the effectiveness of antiseptic agents for meatal cleaning in the prevention of catheter-associated urinary tract infections. J Hosp Infect. 95:233–242. doi:10.1016/j.jhin.2016.10.025
  • Fisher LE, Hook AL, Ashraf W, Yousef A, Barrett DA, Scurr DJ, Chen X, Smith EF, Fay M, Parmenter CDJ, et al. 2015. Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity. J Control Release. 202:57–64. doi:10.1016/j.jconrel.2015.01.037
  • Hamilos DL. 2019. Biofilm formations in pediatric respiratory tract infection: part 1: biofilm structure, role of innate immunity in protection against and response to biofilm, methods of biofilm detection, pediatric respiratory tract diseases associated with mucosal biofilm formation. Curr Infect Dis Rep. 21:6. doi:10.1007/s11908-019-0658-9
  • Haripriyan J, Omanakuttan A, Menon ND, Vanuopadath M, Nair SS, Corriden R, Nair BG, Nizet V, Kumar GB. 2018. Clove bud oil modulates pathogenicity phenotypes of the opportunistic human pathogen Pseudomonas aeruginosa. Sci Rep. 8:3437. doi:10.1038/s41598-018-19771-7
  • ISO. 2009. 10993-5. Biological evaluation of medical devices. Part 5: tests for in vitro cytotoxicity. Geneva (Switzerland): International Organization for Standardization.
  • Ivanova K, Fernandes MM, Francesko A, Mendoza E, Guezguez J, Burnet M, Tzanov T. 2015. Quorum-quenching and matrix-degrading enzymes in multilayer coatings synergistically prevent bacterial biofilm formation on urinary catheters. ACS Appl Mater Interfaces. 7:27066–27077. doi:10.1021/acsami.5b09489
  • Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, Duffy JE, Beyenal H, Lewandowski Z. 2003. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol. 171:4329–4339. doi:10.4049/jimmunol.171.8.4329
  • Kalia VC, Purohit HJ. 2011. Quenching the quorum sensing system: potential antibacterial drug targets. Crit Rev Microbiol. 37:121–140. doi:10.3109/1040841X.2010.532479
  • Kim HS, Lee SH, Byun Y, Park HD. 2015. 6-gingerol reduces Pseudomonas aeruginosa biofilm formation and virulence via quorum sensing inhibition. Sci. Rep. 5. doi:10.4049/10.1038/srep08656
  • Kremserova S, Nauseef WM. 2020. Isolation of human neutrophils from venous blood. In Mark TQ, Frank RD. editors. Neutrophil. New York (NY): Humana; p. 33–42.
  • Leid JG, Shirtliff ME, Costerton JW, Stoodley P. 2002. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun. 70:6339–6345. doi:10.1128/iai.70.11.6339-6345.2002
  • Li WR, Ma YK, Xie XB, Shi QS, Wen X, Sun TL, Peng H. 2018. Diallyl disulfide from garlic oil inhibits Pseudomonas aeruginosa quorum sensing systems and corresponding virulence factors. Front Microbiol. 9:3222. doi:10.3389/fmicb.2018.03222
  • Markakis C, Tsaroucha A, Papalois AE, Lambropoulou M, Spartalis E, Tsigalou C, Romanidis K, Simopoulos C. 2016. The role of eugenol in the prevention of acute pancreatitis-induced acute kidney injury: experimental study. HPB Surg. 2016:3203147. doi:10.1155/2016/3203147
  • Marra A. 2004. Can virulence factors be viable antibacterial targets? Expert Rev Anti Infect Ther. 2:61–72. doi:10.1586/14787210.2.1.61
  • Morais EC, Correa GG, Brambilla R, Radtke C, Baibich IM, dos Santos JHZ. 2013. The interaction of encapsulated pharmaceutical drugs with a silica matrix. Colloids Surf B Biointerfaces. 103:422–429. doi:10.1016/j.colsurfb.2012.10.059
  • Ozcelik B, Ho KKK, Glattauer V, Willcox M, Kumar N, Thissen H. 2017. Poly(ethylene glycol)-based coatings combining low-biofouling and quorum-sensing inhibiting properties to reduce bacterial colonization. ACS Biomater Sci Eng. 3:78–87. doi:10.1021/acsbiomaterials.6b00579
  • Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, et al. 2012. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 380:1927–1935. doi:10.1016/S0140-6736(12)61380-4
  • Pisitsak P, Ruktanonchai U. 2015. Preparation, characterization, and in vitro evaluation of antibacterial sol–gel coated cotton textiles with prolonged release of curcumin. Tex Res J. 85:949–959. doi:10.1177/0040517514557310
  • Pramod K, Ansari SH, Ali J. 2013. UV spectrophotometric method for the quantification of eugenol during in vitro release studies. Asian J. Pharm. 3:86–89. doi:10.1186/s40543-015-0073-2
  • Pramod K, Suneesh CV, Shanavas S, Ansari SH, Ali J. 2015. Unveiling the compatibility of eugenol with formulation excipients by systematic drug-excipient compatibility studies. J Anal Sci Technol. 6:1–14. doi:10.1186/s40543-015-0073-2
  • Radin S, Chen T, Ducheyne P. 2009. The controlled release of drugs from emulsified, sol gel processed silica microspheres. Biomaterials. 30:850–858. doi:10.1016/j.biomaterials.2008.09.066
  • Rajkumari JS, Borkotoky S, Reddy D, Mohanty R, Kumavath SK, Kumavath R, Murali A, Suchiang K, Busi S. 2019. Anti-quorum sensing and anti-biofilm activity of 5-hydroxymethylfurfural against Pseudomonas aeruginosa PAO1: insights from in vitro, in vivo and in silico studies. Microbiol Res. 226:19–26. doi:10.1016/j.micres.2019.05.001
  • Rashid MM, Sarker M. 2014. Dirty waste plastics to crude oil production for refinery. World J Sci Technol Res. 2:1–13.
  • Rathinam P, Vijay Kumar HS, Viswanathan P. 2017. Eugenol exhibits anti-virulence properties by competitively binding to quorum sensing receptors. Biofouling. 33:624–639. doi:10.1080/08927014.2017.1350655
  • Saini H, Chhibber S, Harjai K. 2016. Antimicrobial and antifouling efficacy of urinary catheters impregnated with a combination of macrolide and fluoroquinolone antibiotics against Pseudomonas aeruginosa. Biofouling. 32:511–522. doi:10.1080/08927014.2016.1155564
  • She P, Wang Y, Luo Z, Chen L, Tan R, Wang Y, Wu Y. 2018. Meloxicam inhibits biofilm formation and enhances antimicrobial agents efficacy by Pseudomonas aeruginosa. MicrobiologyOpen. 7:e00545. doi:10.1002/mbo3.545
  • Siddiq DM, Darouiche RO. 2012. New strategies to prevent catheter-associated urinary tract infections. Nat Rev Urol. 9:305–314. doi:10.1038/nrurol.2012.68
  • Skelton-Dudley F, Doan J, Suda K, Holmes SA, Evans C, Trautner B. 2019. Spinal cord injury creates unique challenges in diagnosis and management of catheter-associated urinary tract infection. Top Spinal Cord Inj Rehabil. 25:331–339. doi:10.1310/sci2504-331
  • Soto SM. 2014. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv. Biol. 2014:1–13. doi:10.1155/2014/543974
  • Stark JM, van Egmond AW, Zimmerman JJ, Carabell SK, Tosi MF. 1992. Detection of enhanced neutrophil adhesion to parainfluenza-infected airway epithelial cells using a modified myeloperoxidase assay in a microtiter format. J Virol Methods. 40:225–241. doi:10.1016/0166-0934(92)90071-K
  • Steiner AD, Vargas A, Fronza N, Brandelli A, Dos Santos JHZ. 2017. Antimicrobial activity of some natural extracts encapsulated within silica matrices. Colloids Surf B Biointerfaces. 160:177–183. doi:10.1016/j.colsurfb.2017.09.028
  • Strawbridge I, James P. 1986. The factors affecting the thickness of sol-gel derived silica coatings prepared by dipping. J Non-Cryst Solids. 86:381–393. doi:10.1016/0022-3093(86)90026-8
  • Vargas-Cruz N, Reitzel R, Rosenblatt J, Hachem RY, Chaftari AM, Dib RW, Raad I. 2018. Repeated exposures to minocycline/rifampin and + chlorhexidine combination used to coat catheters fails to induce antimicrobial resistance. Open Forum Infect Dis. 5:S734–S734. doi:10.1093/ofid/ofy210.2106
  • Ying JY, Benziger JB, Navrotsky A. 1993. Structural evolution of alkoxide silica gels to glass: effect of catalyst pH. J Am Ceramic Soc. 76:2571–2582. doi:10.1111/j.1151-2916.1993.tb03983.x
  • Yu Z, Kong Y, Luo Z, Liu T, Lin J. 2019. Anti‑bacterial activity of mutant chensinin‑1 peptide against multidrug‑resistant Pseudomonas aeruginosa and its effects on biofilm‑associated gene expression. Exp Ther Med. 17:2031–2038.doi:10.3892/etm.2019.7182
  • Zhang M, Wang M, Zhu X, Yu W, Gong Q. 2018. Equisetin as potential quorum sensing inhibitor of Pseudomonas aeruginosa. Biotechnol Lett. 40:865–870. doi:10.1007/s10529-018-2527-2
  • Zhang Y, Wang Y, Zhu X, Cao P, Wei S, Lu Y. 2017. Antibacterial and antibiofilm activities of eugenol from essential oil of Syzygium aromaticum (L.) Merr. & L. M. Perry (clove) leaf against periodontal pathogen Porphyromonas gingivalis. Microb Pathog. 113:396–402. doi:10.1016/j.micpath.2017.10.054
  • Zhou L, Zheng H, Tang Y, Yu W, Gong Q. 2013. Eugenol inhibits quorum sensing at sub-inhibitory concentrations. Biotechnol Lett. 35:631–637. doi:10.1007/s10529-012-1126-x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.